Metraipolis › archive › dc_631beca58672

Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42401937
DOI
10.1186/s13048-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-18T11:20:15.845Z
SHA-256 of the archived text
2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d
Stable URL of this page
https://metraipolis.com/documento/dc_631beca58672

How to cite

Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937 — Europe PMC (en), https://europepmc.org/article/MED/42401937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_631beca58672 (Metraipolis archive dc_631beca58672, sha256 2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d)
BibTeX
@misc{dc631beca58672,
  title = {Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42401937},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_631beca58672; sha256 2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42401937. Agents can read the archived copy with the MCP tool read_document.